{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T14:29:32Z","timestamp":1724682572028},"reference-count":55,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Epidemiology"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.jclinepi.2008.07.015","type":"journal-article","created":{"date-parts":[[2008,12,24]],"date-time":"2008-12-24T13:42:43Z","timestamp":1230126163000},"page":"632-641","source":"Crossref","is-referenced-by-count":12,"title":["Hierarchical modeling gave plausible estimates of associations between metabolic syndrome and components of antiretroviral therapy"],"prefix":"10.1016","volume":"62","author":[{"given":"Jim","family":"Young","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy R.","family":"Glass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enos","family":"Bernasconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Rickenbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hansjakob","family":"Furrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Hirschel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip E.","family":"Tarr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Vernazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Battegay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heiner C.","family":"Bucher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jclinepi.2008.07.015_bib1","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/0895-4356(95)00048-8","article-title":"Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates","volume":"48","author":"Peduzzi","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib2","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","article-title":"A simulation study of the number of events per variable in logistic regression analysis","volume":"49","author":"Peduzzi","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib3","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.0006-341X.2000.00915.x","article-title":"When should epidemiologic regressions use random coefficients?","volume":"56","author":"Greenland","year":"2000","journal-title":"Biometrics"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib4","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/00001648-199411000-00009","article-title":"Hierarchical regression analysis applied to a study of multiple dietary exposures and breast cancer","volume":"5","author":"Witte","year":"1994","journal-title":"Epidemiology"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3109\/07853899209147843","article-title":"Empirical Bayes methods for testing associations with large numbers of candidate genes in the presence of environmental risk factors, with applications to HLA associations in IDDM","volume":"24","author":"Thomas","year":"1992","journal-title":"Ann Med"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib6","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","author":"Friis-Moller","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib7","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa062744","article-title":"Class of antiretroviral drugs and the risk of myocardial infarction","volume":"356","author":"Friis-Moller","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib8","first-page":"15","article-title":"Lipid abnormalities during ART: it's the drug, not the class","volume":"14","author":"Moyle","year":"2004","journal-title":"AIDS Read"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib9","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","article-title":"The metabolic syndrome","volume":"365","author":"Eckel","year":"2005","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.jclinepi.2008.07.015_bib10","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.2337\/diacare.27.2007.S5","article-title":"Diagnosis and classification of diabetes mellitus","volume":"27","author":"American Diabetes Association","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib11","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2337\/diacare.28.9.2289","article-title":"The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes","volume":"28","author":"Kahn","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib12","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1468-1293.2006.00400.x","article-title":"Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study","volume":"7","author":"Glass","year":"2006","journal-title":"HIV Med"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib13","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome\u2014a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib14","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1002\/(SICI)1097-0258(19991015)18:19<2655::AID-SIM202>3.0.CO;2-#","article-title":"Analysis of binary outcomes in longitudinal studies using weighted estimating equations and discrete-time survival methods: prevalence and incidence of smoking in an adolescent cohort","volume":"18","author":"Carlin","year":"1999","journal-title":"Stat Med"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib15","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2307\/2530047","article-title":"Covariance adjustment of relative-risk estimates in matched studies","volume":"38","author":"Breslow","year":"1982","journal-title":"Biometrics"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib16","series-title":"Multivariate statistical modelling based on generalized linear models","author":"Fahrmeir","year":"1994"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib17","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/(SICI)1097-0258(20000430)19:8<1059::AID-SIM412>3.0.CO;2-0","article-title":"Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets","volume":"19","author":"Steyerberg","year":"2000","journal-title":"Stat Med"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib18","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/oxfordjournals.aje.a010240","article-title":"Problems due to small samples and sparse data in conditional logistic regression analysis","volume":"151","author":"Greenland","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib19","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1001\/jama.294.2.218","article-title":"Contradicted and initially stronger effects in highly cited clinical research","volume":"294","author":"Ioannidis","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib20","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/sim.4780120802","article-title":"Methods for epidemiologic analyses of multiple exposures\u2014a review and comparative-study of maximum-likelihood, preliminary-testing, and empirical-Bayes regression","volume":"12","author":"Greenland","year":"1993","journal-title":"Stat Med"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib21","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/(SICI)1097-0258(19960615)15:11<1161::AID-SIM221>3.0.CO;2-7","article-title":"Simulation study of hierarchical regression","volume":"15","author":"Witte","year":"1996","journal-title":"Stat Med"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib22","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/ije\/29.1.158","article-title":"Principles of multilevel modelling","volume":"29","author":"Greenland","year":"2000","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2307\/2290687","article-title":"Approximate inference in generalized linear mixed models","volume":"88","author":"Breslow","year":"1993","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib24","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00001648-199507000-00005","article-title":"Dose-response and trend analysis in epidemiology\u2014alternatives to categorical analysis","volume":"6","author":"Greenland","year":"1995","journal-title":"Epidemiology"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2337\/diacare.28.1.132","article-title":"Metabolic syndrome among HIV-infected patients: prevalence, characteristics, and related factors","volume":"28","author":"Jerico","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib26","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.qai.0000219775.20174.2d","article-title":"Metabolic syndrome: a real threat for HIV-positive patients? Results from the SIMONE study","volume":"42","author":"Bonfanti","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib27","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1468-1293.2005.00325.x","article-title":"Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone","volume":"6","author":"Jones","year":"2005","journal-title":"HIV Med"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib28","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1086\/381678","article-title":"The cellular pharmacology of nucleoside- and nucleotide-analogue reverse-transcriptase inhibitors and its relationship to clinical toxicities","volume":"38","author":"Anderson","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib29","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1097\/00002030-200211080-00009","article-title":"Increased long-term mitochondrial toxicity in combinations of nucleoside analogue reverse-transcriptase inhibitors","volume":"16","author":"Walker","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib30","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/01.qai.0000176654.97392.c7","article-title":"Direct comparison of the acute in vivo effects of HIV protease inhibitors on peripheral glucose disposal","volume":"40","author":"Yan","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib31","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1541-0420.2005.00510.x","article-title":"The performance of random coefficient regression in accounting for residual confounding","volume":"62","author":"Gustafson","year":"2006","journal-title":"Biometrics"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib32","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1136\/bmj.312.7040.1215","article-title":"Why we need observational studies to evaluate the effectiveness of health care","volume":"312","author":"Black","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib33","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/jac\/47.4.371","article-title":"Treatment comparisons in HIV infection: the benefits and limitations of observational cohort studies","volume":"47","author":"Sabin","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib34","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/bmj.330.7497.960","article-title":"Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding","volume":"330","author":"Mamdani","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib35","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1097\/00002030-199910220-00010","article-title":"Use of observational databases to evaluate the effectiveness of antiretroviral therapy for HIV infection: comparison of cohort studies with randomized trials. EuroSIDA, the French Hospital Database on HIV and the Swiss HIV Cohort Study Groups","volume":"13","author":"Phillips","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib36","unstructured":"Eg Hansen A-B, Gerstoft J, Kirk O, Mathiesen L, Pedersen C, Nielsen H, et\u00a0al. Unmeasured confounding caused slightly better response to HAART within than outside a randomized controlled trial. J Clin Epidemiol 2008;61:87\u201394."},{"key":"10.1016\/j.jclinepi.2008.07.015_bib37","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2165\/00002018-200528120-00002","article-title":"Do non-nucleoside reverse transcriptase inhibitors contribute to lipodystrophy?","volume":"28","author":"Nolan","year":"2005","journal-title":"Drug Saf"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib38","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.2165\/00003495-200666150-00006","article-title":"Cardiovascular risk in patients with HIV infection\u2014impact of antiretroviral therapy","volume":"66","author":"Bergersen","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib39","doi-asserted-by":"crossref","first-page":"55147","DOI":"10.1074\/jbc.M410826200","article-title":"A structural basis for the acute effects of HIV protease inhibitors on GLUT4 intrinsic activity","volume":"279","author":"Hertel","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib40","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(97)11518-5","article-title":"Visceral abdominal-fat accumulation associated with use of indinavir","volume":"351","author":"Miller","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib41","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/00002030-200204120-00005","article-title":"Indinavir inhibits the glucose transporter isoform GLUT4 at physiologic concentrations","volume":"16","author":"Murata","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib42","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1097\/00002030-200203290-00002","article-title":"Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled study","volume":"16","author":"Noor","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib43","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1097\/00002030-200409030-00017","article-title":"Indinavir increases glucose production in healthy HIV-negative men","volume":"18","author":"Schwarz","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib44","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.292.2.191","article-title":"Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients\u2014a 3-year randomized trial","volume":"292","author":"Gallant","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib45","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/QAI.0b013e31802bf122","article-title":"Less lipoatrophy and better lipid profile with abacavir as compared to stavudine\u201496-week results of a randomized study","volume":"44","author":"Podzamczer","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib46","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1097\/01.qai.0000137003.25258.76","article-title":"New nucleoside\/nucleotide backbone options: a review of recent studies","volume":"37","author":"Ruane","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib47","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/01.qai.0000137002.17634.4e","article-title":"The role of nucleoside and nucleotide reverse transcriptase inhibitor backbones in antiretroviral therapy","volume":"37","author":"Young","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib48","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/sti.77.3.158","article-title":"Mitochondrial toxicity and HIV therapy","volume":"77","author":"White","year":"2001","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib49","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/01.qai.0000224974.67962.ce","article-title":"Tissue-specific associations between mitochondrial DNA levels and current treatment status in HIV-infected individuals","volume":"42","author":"Cherry","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib50","unstructured":"Squillace N, Guaraldi G, Orlando G, Roverato A, Nardini G, Beghetto B, et\u00a0al. The role of virological and immunological parameters on the diagnosis of metabolic syndrome in HIV-associated lipodystrophy. In: Ninth International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, 19\u201321 July 2007, Sydney, Australia [Abstract P38]."},{"key":"10.1016\/j.jclinepi.2008.07.015_bib51","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1532-5415.1999.tb01603.x","article-title":"Assessment and control for confounding by indication in observational studies","volume":"47","author":"Psaty","year":"1999","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jclinepi.2008.07.015_bib52","unstructured":"De Wit S, Sabin CA, Weber R, Worm SW, Reiss P, Thiebaut R, et\u00a0al. Relationship between use of stavudine and diabetes mellitius. In: Eigth International Congress on Drug Therapy in HIV Infection, 12\u201316 November 2006, Glasgow, UK [Abstract PL9.5]."},{"key":"10.1016\/j.jclinepi.2008.07.015_bib53","unstructured":"Worm SW, Sabin CA, El Sadr WM, Reiss P, D'Arminio Monforte A, Rickenbach M, et\u00a0al. The metabolic syndrome at baseline in the D:A:D study. In: Eighth International Congress on Drug Therapy in HIV Infection, 12\u201316 November 2006, Glasgow, UK. [Abstract P124]."},{"key":"10.1016\/j.jclinepi.2008.07.015_bib54","unstructured":"Worm SW, Sabin CA, Reiss P, El-Sadr W, D'Arminio Monforte A, Law M, et\u00a0al. Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components: data from the D:A:D Study. In: Fourteenth Conference on Retrovirus and Opportunistic Infections, 25\u201328 February 2007, Los Angeles, USA. A815."},{"key":"10.1016\/j.jclinepi.2008.07.015_bib55","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/00001648-200011000-00012","article-title":"Multilevel modeling in epidemiology with GLIMMIX","volume":"11","author":"Witte","year":"2000","journal-title":"Epidemiology"}],"container-title":["Journal of Clinical Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435608002333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435608002333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T05:14:35Z","timestamp":1684818875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0895435608002333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0895435608002333"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinepi.2008.07.015","relation":{},"ISSN":["0895-4356"],"issn-type":[{"value":"0895-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}